Zobrazeno 1 - 10
of 79
pro vyhledávání: '"A Abdolzade-Bavil"'
Autor:
Belli, Sara, Amann, Maria, Hutchinson, Lucy, Pousse, Laurène, Abdolzade‐Bavil, Afsaneh, Justies, Nicole, Jacobsen, Bjoern, Ploix, Corinne, Tselempi, Eleni, Tosevski, Vinko, Koll, Hans, Schnetzler, Gabriel, Boetsch, Christophe, Marrer‐Berger, Estelle
Publikováno v:
Clinical Pharmacology & Therapeutics; Sep2024, Vol. 116 Issue 3, p834-846, 13p
Autor:
Kelly, Kevin R *, Ailawadhi, Sikander, Siegel, David S, Heffner, Leonard T, Somlo, George, Jagannath, Sundar, Zimmerman, Todd M, Munshi, Nikhil C, Madan, Sumit, Chanan-Khan, Asher, Lonial, Sagar, Chandwani, Suraj, Minasyan, Ashot, Ruehle, Markus, Barmaki-Rad, Farima, Abdolzade-Bavil, Afsaneh, Rharbaoui, Faiza, Herrmann-Keiner, Eva, Haeder, Thomas, Wartenberg-Demand, Andrea, Anderson, Kenneth C
Publikováno v:
In The Lancet Haematology November 2021 8(11):e794-e807
Autor:
Arthur J. Van De Vyver, Antje-Christine Walz, Mariette S. Heins, Afsaneh Abdolzade-Bavil, Thomas E. Kraft, Inja Waldhauer, Michael B. Otteneder
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Monoclonal antibodies play an important role in the treatment of various diseases. However, the development of these drugs against neurological disorders where the drug target is located in the brain is challenging and requires a good understanding o
Externí odkaz:
https://doaj.org/article/3178277d91194c33ad0c97715f1819eb
Autor:
S. Tourdot, A. Abdolzade-Bavil, J. Bessa, P. Broët, A. Fogdell-Hahn, M. Giorgi, V. Jawa, K. Kuranda, N. Legrand, S. Pattijn, J. A. Pedras-Vasconcelos, A. Rudy, P. Salmikangas, D. W. Scott, V. Snoeck, N. Smith, S. Spindeldreher, D. Kramer
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
Therapeutic proteins and emerging gene and cell-based therapies are attractive therapeutic tools for addressing unmet medical needs or when earlier conventional treatment approaches failed. However, the development of an immune response directed agai
Externí odkaz:
https://doaj.org/article/a03c2302b1744d6187c57a29775e0058
Autor:
Sagar Lonial, Afsaneh Abdolzade-Bavil, Asher Chanan-Khan, Markus Ruehle, Farima Barmaki-Rad, Nikhil C. Munshi, Suraj Chandwani, George Somlo, Kevin R. Kelly, Sundar Jagannath, Ashot Minasyan, Sumit Madan, Andrea Wartenberg-Demand, Eva Herrmann-Keiner, Todd M. Zimmerman, Leonard T. Heffner, Sikander Ailawadhi, Faiza Rharbaoui, Thomas Haeder, David S. Siegel, Kenneth C. Anderson
Publikováno v:
The Lancet Haematology. 8:e794-e807
Summary Background Indatuximab ravtansine (BT062) is an antibody-drug conjugate that binds to CD138 and synergistically enhances the antitumor activity of lenalidomide in preclinical models of multiple myeloma. This phase 1/2a study was done to deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0615d00fca68dbeca53ac09dba128790
https://doi.org/10.1016/s2352-3026(21)00208-8
https://doi.org/10.1016/s2352-3026(21)00208-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christian Künzel, Kay Stubenrauch, Alfred Engel, Eginhard Schick, Afsaneh Abdolzade-Bavil, Mirko Pleitner
Publikováno v:
Bioanalysis. 13:253-263
Aim: Development and qualification of an easy-to-use ELISA for detection of IgM anti-drug antibodies (ADA) and its use in a clinical Phase I trial. Results & methodology: During the assay development two positive control (PC) approaches, the preparat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45a0cbf568e26f70a50eeaf35027800
https://doi.org/10.4155/bio-2020-0308
https://doi.org/10.4155/bio-2020-0308
Autor:
N Smith, Daniel Kramer, D W Scott, P Salmikangas, Anna Fogdell-Hahn, Sebastian Spindeldreher, Vibha Jawa, S Pattijn, V Snoeck, Joao Pedras-Vasconcelos, N Legrand, Philippe Broët, Sophie Tourdot, J Bessa, K Kuranda, A Rudy, Mario Giorgi, A Abdolzade-Bavil
Publikováno v:
mAbs
Therapeutic proteins and emerging gene and cell-based therapies are attractive therapeutic tools for addressing unmet medical needs or when earlier conventional treatment approaches failed. However, the development of an immune response directed agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c3bc11e209336f4504a1a80229f96f1
https://doi.org/10.1080/19420862.2020.1725369
https://doi.org/10.1080/19420862.2020.1725369
Two phase I, single-blind (subject blinded to treatment), randomized studies were conducted to assess the pharmacodynamics, pharmacokinetics, safety, and tolerability of lipegfilgrastim compared with pegfilgrastim in healthy adult volunteers. Study 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8179271f0c6ae015e023400e06733fc9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.